medigraphic.com
ISSN 1870-2821 (Impreso)
Organo Oficial de la Asociación Mexicana de Mastología

2006, Número 1

<< Anterior Siguiente >>

Rev Mex Mastol 2006; 1 (1)


El papel de la impronta transoperatoria en la evaluación del ganglio centinela en mujeres con cáncer de mama. Experiencia del Hospital de Oncología

Barroso-Bravo S, Alvarado-Cabrero I, Mantilla A, Rojas ME, Nájera I, Zarco G, Gómez TM

Idioma: Español
Referencias bibliográficas: 35
Paginas: 8-12
Archivo PDF: 83.80 Kb.


RESUMEN

Antecedentes: Cuando se ha establecido como rutina el mapeo ganglionar y la BGC, la evaluación del GC es fundamental para decidir si se efectúa el vaciamiento axilar. Es aquí que la impronta citológica transoperatoria juega un papel fundamental; el objetivo del estudio fue demostrar la seguridad diagnóstica del método. Método: Se hizo una revisión retrospectiva de mujeres con cáncer de mama EC 0, I y II con ganglios negativos y que fueron sometidas a mapeo ganglionar y BGC con evaluación citológica transoperatoria del GC para conocer la seguridad diagnóstica de la prueba. Resultados: Del 1° de marzo de 2002 al 28 de febrero de 2004, se analizaron 100 casos de mujeres con cáncer de mama temprano sometidas a MG y BGC, los valores resultantes de la impronta citológica transoperatoria del GC fueron sensibilidad de 80%, especificidad de 98%, VPP 95% y VPN 93%. Conclusiones: Los resultados muestran que la impronta citológica transoperatoria es una prueba diagnóstica segura y útil en nuestro medio.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Giuliano AE. Current status of sentinel lymphadenectomy in breast cancer. Ann Surg Oncol 2001; 8: 52S-55S.

  2. Krag D. Minimal invasive staging for breast cancer: Clinical experience with sentinel lymph node biopsy. Semin in Oncol 2001; 28(3): 229-235.

  3. Miltenburg DM, Millar C, Karamlov TB, Brunicardi FC. Meta -analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999; 84: 138-142.

  4. Cantin J, Scarth H, Levine M, Hugi M. Clinical practice guidelines for the care and treatment of breast cancer. Can Med Ass J 2001; 165(2): 166-173.

  5. Schwartz GF, Giuliano AE, Veronesi U. Proceeding of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast. April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2002; 13: 2542-2553.

  6. Practice Guideline in Oncology 2003. Guideline Index Breast Cancer. National Comprehensive Cancer Network.

  7. Fisher B, Redmon C, Fisher ER, Bauer M, Wolmark N, Wickerham DL et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674-81.

  8. Renolleau C, Merviel P, Clough KB, Asselain B, Campana F, Durand JC. Isolated axillary recurrences after conservative treatment of breast cancer. Eur J Cancer 1996; 32A: 617-21.

  9. Cabares PA, Salmon RJ, Vilcoq JR, Durand JC, Forquet A, Gautier C et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institute Curie. Lancet 1992; 339: 1245-1248.

  10. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992; 66: 136-8.

  11. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer 1996; 76: 1491-1512.

  12. Morrow M. Role of axillary dissection in breast cancer management. Ann Surg Oncol 1996; 3: 233-4.

  13. McIntosh SA, Purushotham AD. Lymphatic mapping and sentinel node biopsy in breast cancer. Br J Surg 1998; 85: 1347-56.

  14. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997; 349: 1864-7.

  15. Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Noguchi S et al. Sentinel node biopsy in breast cancer patient with clinically negative lymph nodes. Breast Cancer 1999; 6: 259-62.

  16. Bass SS, Lyman GH, McCann CR, Ku NN, Berman C, Durand K, Bolano M, Cox S, Salud C, Reintgen DS, Cox CE. Lymphatic Mapping and sentinel lymph node biopsy. Breast J 1999; 5: 288-295.

  17. Cox CE. Lymphatic mapping in breast cancer: combination technique. Ann Surg Oncol 2001; 8: 67S-70S.

  18. Krag D, Weaver D, Ashikaga T, Muffed F, Climber VS, Shiver C, Feldman S, Kaminski R, Gad M, Kuhn J, Harlow S, Bewitch P. The sentinel node in breast cancer a multimember validation studies. N Engl J Med 1998; 339: 941-946.

  19. O´Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, Borgen PI, Cody HS. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-427.

  20. Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg VS. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 1998; 5: 689-94.

  21. Van Diest PJ, Torrenga H, Borgstein PJ, Pijpers R, Bleichrodt RP, Rahusen FD, Meijer S. Reliability of intraoperative frozen section imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 1999; 35: 14-18.

  22. Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Noguchi S, Koyama H. Intraoperative sentinel lymph node examination by imprint cytologic and frozen sectioning during breast surgery. Br J Surg 2000; 87(5): 597-601.

  23. Gulec SA, Su J, O’Leary JP, Stolier A. Clinical utility of frozen section in sentinel node biopsy in breast cancer. Am Surg 2001; 67: 529-532.

  24. Chou SH, Borsky SH, Chang HR. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer. Breast Journal 9(3): 153-62.

  25. Chao C, Wong SL, Ackerman D, Simpson D, Carter MB, Brown CM, Edwards MJ, Mc Master KM. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg 2001; 182(6): 609-15.

  26. Van der Loo EM, Sastrowjoto SH, Brill H, van Krimpen C, de Graaf PW, Eulderink F. Less operation required due to perioperative frozen section examination of sentinel nodes in 275 breast cancer patients. Nederlands Tijdschrift von Geneeskunde 2001; 145(4): 1986-91.

  27. Henry-Tillman R, Korourian S, Rubio I, Johnson A, Mancino AT. Intraoperative touch preparation for Sentinel Lymph Node Biopsy: a 4 year Experience. Annals of Surgical Oncology 2002; 9(4): 333-339.

  28. Weiser MR, Montgomery LL, Susnik B, Tan LK, Borgen PI, Cody HS. Is routine intraoperative frozen section examination of sentinel lymph nodes in breast cancer worthwhile? Ann Surg Oncol 2000; 7: 651-655.

  29. Liang WC, Sickle-Santanello BJ, Nims TA. Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? Am J Surg 2001; 182(4): 365-8.

  30. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999; 229: 536-541.

  31. Bochner MA, Farshid G, Dodd TJ, Kollins J, Gill PG. Intraoperative imprint cytologic assessment of the sentinel node for early breast cancer. World J Surg 2003; 27(4): 430-2.

  32. Mullenix PS, Carter PL, Martin MJ, Steele SR, Scott CL, Walts MJ, Beitler AL. Predictive value intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastases in breast cancer. Am J Surg 2003; 185(5): 420-4.

  33. Shirov SA, Creager AJ, Geisinger K, Perrier N, Shen P, Levine EA. Intraoperative analysis of sentinel lymph nodes by imprint cytologic for cancer of the breast. Am J Surg 2002; 184: 424-427.

  34. Kane JM 3rd, Edge SB, Winston JS, Watroba N, Hurd TC. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol 2001; 8: 361-367.

  35. Salem AA, Douglas-Jones AG, Sweetland HM, Newcombe RG, Mansel RE. Evaluation of axillary lymph nodes using touch imprint cytologic and immunohistochemistry. Br J Surg 2002; 89: 1386-1389.




2020     |     www.medigraphic.com